Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, below historical average.
Left:
||||
Free cash flow yield
Latest
-12.60%
↓ 27% below average
Average (9y)
-9.94%
Historical baseline
Range
High:6.17%
Low:-47.91%
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | -12.60% | +71.5% |
| 2024 | -44.12% | +7.9% |
| 2023 | -47.91% | -489.1% |
| 2022 | -8.13% | -31.7% |
| 2021 | -6.17% | -1098.7% |
| 2020 | 0.62% | -89.0% |
| 2019 | 5.61% | +271.3% |
| 2018 | 1.51% | -73.1% |
| 2017 | 5.62% | -8.9% |
| 2016 | 6.17% | - |